.Merely five months after protecting a $100 thousand IPO, Vast Bio is actually currently laying off ...
.The preliminary stages of oncology R&D may not be short of fascinating brand-new methods, as wel...
.Psychopharmacology has actually taken 3 short articles concerning midstage scientific trial records...
.Avidity Biosciences impressed investors with phase 1/2 data in Duchenne muscular dystrophy (DMD) Fr...
.Actinogen Medical's cortisol blocker has actually overlooked the key endpoint of a phase 2 study in...
.Antibody-drug conjugates (ADCs) have been at the center of several a billion-dollar biobuck licensi...
.Resource manager TPG, which has sustained biotechs like Sionna Therapies and Santa Clam Ana Bio, ha...
.Merck & Co.'s TIGIT program has gone through an additional trouble. Months after shuttering a st...
.After a year described by pipeline cuts, the departure of its CEO and also layoffs, Exscientia will...
.Cullinan Therapy was impressed good enough with Port BioMed's bispecific invulnerable reactor that ...